Awardee OrganizationICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Description
Abstract Text
DESCRIPTION (provided by applicant):
The development of definitive endoderm and its subsequent specification leads to the formation of many of the major organs including the liver, pancreas, lungs, thyroid, and intestines. Under appropriate culture conditions, mouse embryonic stem (ES) cells differentiate into embryoid bodies (EBs) that contain derivatives of all three germ layers. Most of these studies have focused on the development of mesoderm and ectoderm derivatives. The development of hematopoietic, vascular, muscle and neuronal lineages were found to parallel that in the early embryo, thus validating the ES system for early developmental studies. More recently, studies have provided evidence for endoderm development in ES differentiation cultures and demonstrated the generation of insulin expressing cells and cells with hepatocyte characteristics. ES studies have not yet established conditions for the efficient induction of endoderm or its specification to liver.
This proposal addresses these issues by investigating specific steps of development including (1) induction of ES cells to an endoderm fate, (2) specification of endoderm into a hepatocyte progenitor, called the hepatoblast and (3) maturation of the hepatoblast into a functional hepatocyte. Thus, the liver is the focus in this application as an endoderm-derived tissue. Early endoderm fated cells as well as the hepatoblast will be characterized from ES cell cultures using cell sorting analysis. The liver repopulation potential of endoderm-derived cells will be analyzed in two mouse models of liver failure. The project will also seek to translate the murine ES cell differentiation program to optimize the generation of human hepatocytes. Therefore, the ultimate goal of these studies is to develop a feasible approach to generate functional hepatocytes from ES ells and to understand the mechanisms that orchestrate the hepatocyte development from ES cells.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
848
DUNS Number
078861598
UEI
C8H9CNG1VBD9
Project Start Date
15-September-2005
Project End Date
30-June-2010
Budget Start Date
01-July-2006
Budget End Date
30-June-2007
Project Funding Information for 2006
Total Funding
$129,465
Direct Costs
$119,875
Indirect Costs
$9,590
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Diabetes and Digestive and Kidney Diseases
$129,465
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K01DK068041-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K01DK068041-02
Patents
No Patents information available for 5K01DK068041-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K01DK068041-02
Clinical Studies
No Clinical Studies information available for 5K01DK068041-02
News and More
Related News Releases
No news release information available for 5K01DK068041-02
History
No Historical information available for 5K01DK068041-02
Similar Projects
No Similar Projects information available for 5K01DK068041-02